Figure S3. Distribution of TRIM28 expression level in MAGEC2-positive and MAGEC2-negative tissues of hepatocellular carcinoma patients. Human hepatocellular carcinoma tissues were immunohistochemically stained with anti-MAGEC2 or anti-TRIM28 antibodies, and H score was assigned to each sample for MAGEC2 and TRIM28, respectively. (JPG 55Â kb
Gene expression of the selected marker set in normal (n = 49), adenoma (n = 49), and tumour (n = 49)...
Figure S1. Scatter plots for sample pairs. Scatter plots of % methylation values for each pair in no...
Figure S3. (a, b, c, d) Western blotting (left panel; a, c) and qRT-PCR (right panel; b, d) were use...
Figure S1. Expression levels of TRIM28 and MAGEC2 are detected in different tumor cell lines. A375, ...
Figure S2. Overexpression of TRIM28 does not affect exogenous MAGEC2 mRNA level in AsPC1 cells. pCL-...
Figure S4. Knockdown of MAGEC2 does not affect TRIM28 expression. MAGEC2-specific siRNAs or control ...
Additional file 2: Figure S2. The expression level of CTD-2547G23.4 in HCC. (A) Forest plot of all e...
Figure S1. B3GALNT2 levels determined by W.B. and ROC curve. aâc Relative mRNA expression of B3GAL...
Figure S2. (A) Expression of the BD-hTiam1-C1199 clones detected by anti-c-Myc antibody. (ladder1:BD...
Re-expression of CD38 in prostate cancer cell lines after treatment with DNA methyltransferase inhib...
Additional file 1: Figure S1. Cancer testis antigen (CTA) expression patterns across normal tissue. ...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
To identify Cyclin A1-expressing solid cancer entities, HG U133 Plus 2.0 microarray data sets (Affym...
Figure S1. SMAD4 is loss in colorectal cancer and correlated with poor prognosis. (A) Representative...
Figure S2. Validation of TRIM3 expression levels in TRIM3 overexpression and knockdown cells. a and ...
Gene expression of the selected marker set in normal (n = 49), adenoma (n = 49), and tumour (n = 49)...
Figure S1. Scatter plots for sample pairs. Scatter plots of % methylation values for each pair in no...
Figure S3. (a, b, c, d) Western blotting (left panel; a, c) and qRT-PCR (right panel; b, d) were use...
Figure S1. Expression levels of TRIM28 and MAGEC2 are detected in different tumor cell lines. A375, ...
Figure S2. Overexpression of TRIM28 does not affect exogenous MAGEC2 mRNA level in AsPC1 cells. pCL-...
Figure S4. Knockdown of MAGEC2 does not affect TRIM28 expression. MAGEC2-specific siRNAs or control ...
Additional file 2: Figure S2. The expression level of CTD-2547G23.4 in HCC. (A) Forest plot of all e...
Figure S1. B3GALNT2 levels determined by W.B. and ROC curve. aâc Relative mRNA expression of B3GAL...
Figure S2. (A) Expression of the BD-hTiam1-C1199 clones detected by anti-c-Myc antibody. (ladder1:BD...
Re-expression of CD38 in prostate cancer cell lines after treatment with DNA methyltransferase inhib...
Additional file 1: Figure S1. Cancer testis antigen (CTA) expression patterns across normal tissue. ...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
To identify Cyclin A1-expressing solid cancer entities, HG U133 Plus 2.0 microarray data sets (Affym...
Figure S1. SMAD4 is loss in colorectal cancer and correlated with poor prognosis. (A) Representative...
Figure S2. Validation of TRIM3 expression levels in TRIM3 overexpression and knockdown cells. a and ...
Gene expression of the selected marker set in normal (n = 49), adenoma (n = 49), and tumour (n = 49)...
Figure S1. Scatter plots for sample pairs. Scatter plots of % methylation values for each pair in no...
Figure S3. (a, b, c, d) Western blotting (left panel; a, c) and qRT-PCR (right panel; b, d) were use...